lenalidomide has been researched along with Franklin Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, A; Shibata, S | 1 |
| Fulciniti, M; Lee, SH; Leslie, CS; Mayr, C; Munshi, NC; Samur, MK; Singh, I; Sperling, AS; Tai, YT | 1 |
2 other study(ies) available for lenalidomide and Franklin Disease
| Article | Year |
|---|---|
Gamma heavy chain disease complicated by pulmonary hypertension, which was successfully treated with lenalidomide.
Topics: Aged; Bone Marrow; Bortezomib; Dexamethasone; Drug Therapy, Combination; Heavy Chain Disease; Humans; Hypertension, Pulmonary; Immunoglobulin G; Immunologic Factors; Lenalidomide; Male | 2020 |
Widespread intronic polyadenylation diversifies immune cell transcriptomes.
Topics: 3' Untranslated Regions; Angiogenesis Inhibitors; Case-Control Studies; Gene Expression; Gene Library; Gene Ontology; Heavy Chain Disease; Humans; Immunoglobulin mu-Chains; Introns; Lenalidomide; Multiple Myeloma; Plasma Cells; Polyadenylation; Primary Cell Culture; Progression-Free Survival; Transcriptome | 2018 |